In conclusion, CSF1 and CSF2 are important factors involved in TAM recruitment and glioma progression and, therefore, the inhibitors of CSF1 and CSF2 signaling could be further explored for their potential beneficial effects in GBM [212]. This evidence concerns the gene CSF1 and central nervous system cancer.